Two Sigma Investments »

Alnylam Pharmaceuticals shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2011-12-31 $436k 54k 8.15

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Carnival Corp Unit 99/99/9999 Put Option (CCL)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A (META)
Carvana Cl A (CVNA)
Snowflake Cl A (SNOW)
Bristol Myers Squibb (BMY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Amazon (AMZN)
Robinhood Mkts Com Cl A (HOOD)
Uber Technologies Put Option (UBER)

View all positions for Two Sigma Investments

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals